Inventor · disambiguated record
Eli M. Wallace
Also filed as: WALLACE ELI · WALLACE ELI M
92 granted patents·31 pending applications·1,029 citations·filing 1999–2025
99Inventor score
Files withARRAY BIOPHARMA INC56PELOTON THERAPEUTICS INC15BLAKE JAMES F7MARLOW ALLISON L7WALLACE ELI M6
Top patents by PatentIndex Score
123 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0296US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 0396US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 0496US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0596US7425637B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2005·Granted Sep 16, 2008·27 cites·1 claims
- 0696US6197798B1Amino-benzocycloalkane derivativesNOVARTIS AG·Filed 1999·Granted Mar 6, 2001·108 cites·16 claims
- 0795US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0895US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 0995US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 1094US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 1194US7777050B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 17, 2010·13 cites·9 claims
- 1293USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 1393US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 1493US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 1593US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 1693US8324221B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 4, 2012·54 cites·60 claims
- 1793US8178131B2Pyrrolopyridines as kinase inhibitorsLE HUEROU YVAN·Filed 2009·Granted May 15, 2012·24 cites·36 claims
- 1893US7235537B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jun 26, 2007·53 cites·10 claims
- 1992US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 2092US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 2192US7271178B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 18, 2007·18 cites·17 claims
- 2291US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 2391US7538120B2Method of treating inflammatory diseasesARRAY BIOPHARMA INC·Filed 2005·Granted May 26, 2009·11 cites·9 claims
- 2490US9676791B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2012·Granted Jun 13, 2017·5 cites·9 claims
- 2590US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 2690US8981085B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Mar 17, 2015·10 cites·20 claims
- 2790US8372842B2Pyrazolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Feb 12, 2013·15 cites·53 claims
- 2889US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 2989US9969727B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted May 15, 2018·6 cites·23 claims
- 3089US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 3189US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 3289US7501427B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Mar 10, 2009·14 cites·37 claims
- 3389US7144907B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2003·Granted Dec 5, 2006·33 cites·34 claims
- 3488US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 3588US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 3688US7576114B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 18, 2009·5 cites·1 claims
- 3787US10335388B2Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·4 cites·21 claims
- 3887US10278942B2Compositions for use in treating pulmonary arterial hypertensionPELOTON THERAPEUTICS INC·Filed 2016·Granted May 7, 2019·7 cites·16 claims
- 3987US9365568B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jun 14, 2016·4 cites·12 claims
- 4087US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 4187US8431574B2Heterocyclic inhibitors of MEK and methods of use thereofBLAKE JAMES F·Filed 2009·Granted Apr 30, 2013·6 cites·6 claims
- 4287US8329709B25H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 11, 2012·10 cites·33 claims
- 4387US8236825B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2011·Granted Aug 7, 2012·7 cites·24 claims
- 4487US7511058B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Mar 31, 2009·8 cites·18 claims
- 4586US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 4686US8758830B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jun 24, 2014·6 cites·27 claims
- 4786US8513293B2Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammalWALLACE ELI M·Filed 2012·Granted Aug 20, 2013·5 cites·4 claims
- 4886US8003805B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2010·Granted Aug 23, 2011·5 cites·7 claims
- 4986US7973170B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2010·Granted Jul 5, 2011·5 cites·7 claims
- 5086US7230099B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Jun 12, 2007·30 cites·15 claims
Showing the top 50 of 123 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →